During his research for a cover story, journalist Tom Berner uncovers a major story: Are Islamist terrorists buying ingredients online to create pathogens for the deadly Ebola virus? The evidence suggests so: In Istanbul, Berner encounters a biotech company that appears to support terrorism. However, when an assassination attempt on the journalist occurs in the middle of Rome, he realizes that there is more to the case than initially thought.